Drug utilization analysis of osteoporosis medications in seven European electronic health databases-Reference-Cited by-同舟云学术

Drug utilization analysis of osteoporosis medications in seven European electronic health databases

Published:2023-07-12 Issue:10 Volume:34 Page:1771-1781
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Tan Eng Hooi,Robinson Danielle E.,Jödicke Annika M.,Mosseveld Mees,Bødkergaard Katrine,Reyes Carlen,Moayyeri Alireza,Voss Annemarie,Marconi Ettore,Lapi Francesco,Reinold Jonas,Verhamme Katia M. C.,Pedersen Lars,Braitmaier Malte,de Wilde Marcel,Ruiz Marc Far,Aragón María,Bosco-Levy Pauline,Lassalle Regis,Prieto-Alhambra Daniel^ORCID,Sanchez-Santos Maria T.

Funder

UCB Biopharma SRL and Amgen Inc requested by EMA

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-023-06837-0.pdf

Reference29 articles.

1. Kanis JA, Cooper C, Rizzoli R, Reginster JY (2019) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 30(1):3–44

2. Crandall CJ, Newberry SJ, Diamant A, Lim YW, Gellad WF, Booth MJ et al (2014) Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review. Ann Intern Med 161(10):711–723

3. Gregson CL, Armstrong DJ, Bowden J, Cooper C, Edwards J, Gittoes NJL et al (2022) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 17(1):58